All In Biotech

Drug Trial Radar · NCT01096784

IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study

Last checked: Nov 20, 2026Latest source record: Jun 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

Jun 18, 2010

Primary completion

Mar 30, 2016

Study completion Mar 30, 2016

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Mar 31, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, up to 1 day
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the severity of retinopathy of prematurity (ROP) among treated infants with an untreated control population, matched for gestational age at birth while confirming the dose of rhIGF-1/rhIGFBP-3 is safe and efficacious.

Conditions

  • Retinopathy of Prematurity (ROP)

Interventions

  • rhIGF-I/rhIGFBP-3Drug

    Continuous intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Severity of Retinopathy of Prematurity (ROP) as Compared to the Severity of ROP in an Untreated Control PopulationTime frame: End of study

Locations

24 sites in 6 countries. Site status is shown where the registry gives one.

  • University of South Alabama Children's and Women's Hospital

    Mobile, Alabama

  • Univ of California Irvine Med Center

    Irvine, California

  • Georgia Regents Medical Center

    Augusta, Georgia

  • Univ of Mississippi Medical Center

    Jackson, Mississippi

  • Vidant Medical Center

    Greenville, North Carolina

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • West Virginia University Hospital

    Morgantown, West Virginia

  • University of Wisconsin - Madison

    Madison, Wisconsin

  • D.A.I. Materno Infantile, S.O.D. Neonatologia e Terapia Intensiva Neonatale - Azienda Ospedaliero-Universitaria Careggi

    Florence, Italy

  • U.O.C Patologia e Terapia Intensiva Neonatale, Istituto Giannina Gaslini-Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico

    Genova, Italy

  • University of Padua

    Padua, Italy

  • Dipartimento per la Tutella della Salute della Donna e della Vita Nascente, del Bambino e dell'Adolescente-U.O.C. Neonatologia-Poli. Gemelli

    Rome, Italy

  • VU medical Center

    Amsterdam, Netherlands

  • Instytut Centrum Zdrowia Matki Polki

    Lódz, Poland

  • Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego w Poznani

    Poznan, Poland

  • Skånes University Hospital Lund

    Lund, Sweden

  • Karolinska Universtitetssjukhuset i Huddinge

    Stockholm, Sweden

  • Addenbrookes Hospital

    Cambridge, United Kingdom

  • St Peter's Hospital; Ashford & S

    Chertsey, United Kingdom

  • University Hospital

    Coventry, United Kingdom

  • Alder Hey Children's NHS Foundation Trust

    Liverpool, United Kingdom

  • UCL EGA Institute for Women's Health

    London, United Kingdom

  • St. Mary's Hospital

    Manchester, United Kingdom

  • Norfolk and Norwich University

    Norwich, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.